Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tolerability to romidepsin in patients with relapsed/refractory T-cell lymphoma.
Foss F, Coiffier B, Horwitz S, Pro B, Prince HM, Sokol L, Greenwood M, Lerner A, Caballero D, Baran E, Kim E, Nichols J, Balser B, Wolfson J, Whittaker S. Foss F, et al. Among authors: lerner a. Biomark Res. 2014 Sep 8;2:16. doi: 10.1186/2050-7771-2-16. eCollection 2014. Biomark Res. 2014. PMID: 25279222 Free PMC article.
A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma.
Foss F, Advani R, Duvic M, Hymes KB, Intragumtornchai T, Lekhakula A, Shpilberg O, Lerner A, Belt RJ, Jacobsen ED, Laurent G, Ben-Yehuda D, Beylot-Barry M, Hillen U, Knoblauch P, Bhat G, Chawla S, Allen LF, Pohlman B. Foss F, et al. Among authors: lerner a. Br J Haematol. 2015 Mar;168(6):811-9. doi: 10.1111/bjh.13222. Epub 2014 Nov 17. Br J Haematol. 2015. PMID: 25404094 Free article. Clinical Trial.
Infliximab as a therapy for idiopathic hypereosinophilic syndrome.
Taverna JA, Lerner A, Goldberg L, Werth S, Demierre MF. Taverna JA, et al. Among authors: lerner a. Arch Dermatol. 2007 Sep;143(9):1110-2. doi: 10.1001/archderm.143.9.1110. Arch Dermatol. 2007. PMID: 17875870 No abstract available.
1,464 results